In the burgeoning arena of precision therapies for genetically defined diseases, Cogent Biosciences, Inc. is carving out a distinct and trailblazing path. The biotech powerhouse, with dual headquarters in Waltham, MA and Boulder, CO, is redefining the battle against grave diseases by focusing on the molecular minutiae that underpin these conditions. Cogent’s flagship clinical program, […]